S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

AKBA Akebia Therapeutics Inc

2.08

0.15 (7.77%)

Jan 17 2025 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Akebia Therapeutics (NASDAQ:AKBA)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Akebia Therapeutics Charts.

Akebia Therapeutics (NASDAQ:AKBA)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Akebia Therapeutics Charts.

Akebia Therapeutics Inc News

Form 8-K - Current report
Monday 13 January 2025 (5 days ago) • Edgar (US Regulatory)

Akebia Therapeutics Announces Multiple Positive Business Updates
Monday 13 January 2025 (5 days ago) • PR Newswire (US)

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Thursday 2 January 2025 (2 weeks ago) • PR Newswire (US)

Akebia Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Wednesday 18 December 2024 (1 month ago) • PR Newswire (US)

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tuesday 3 December 2024 (1 month ago) • PR Newswire (US)

U.S. Renal Care Enrolled First Patients in the VOICE Collaborative Clinical Trial of Vafseo® (vadadustat) for CKD Patients on Dialysis
Tuesday 3 December 2024 (2 months ago) • PR Newswire (US)

Akebia Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference
Monday 25 November 2024 (2 months ago) • PR Newswire (US)

Vadadustat Alternative Dosing Study Results Published in the American Journal of Kidney Disease
Thursday 14 November 2024 (2 months ago) • PR Newswire (US)

Akebia Therapeutics to Present at the Jefferies London Healthcare Conference
Tuesday 12 November 2024 (2 months ago) • PR Newswire (US)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

More Akebia Therapeutics Inc News Articles

Invesco MSCI Global Timb...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions